ஸ்கிசோஃப்ரினியா புல்லட்டின் திறந்த News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஸ்கிசோஃப்ரினியா புல்லட்டின் திறந்த. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஸ்கிசோஃப்ரினியா புல்லட்டின் திறந்த Today - Breaking & Trending Today

Brexpiprazole Provides Short- and Long-Term Benefits in Schizophrenia

Atypical antipsychotic brexpiprazole seems to have short- and long-term benefits across schizophrenia symptoms based on PANSS and five subscales. ....

Otsuka Pharmaceutical Development Commercialization , Schizophrenia Bulletin Open , Negative Syndrome Scale , Otsuka Pharmaceutical Development , ஓத்சுக் மருந்து வளர்ச்சி வணிகமயமாக்கல் , ஸ்கிசோஃப்ரினியா புல்லட்டின் திறந்த , எதிர்மறை நோய்க்குறி அளவு , ஓத்சுக் மருந்து வளர்ச்சி ,

Brexpiprazole Provides Short- and Long-Term Benefits in Schizophrenia

Credit: Getty Images
Schizophrenia Bulletin Open confirms.
The study analyzed clinical trial reports to determine short- and long-term effects of brexpiprazole across schizophrenia symptoms based on the Positive and Negative Syndrome Scale (PANSS) and five subscales.
To study short-term effects, the researchers used data from 3 randomized, double-blind, placebo-controlled brexpiprazole studies in patients with acute schizophrenia. Long-term maintenance effects were studied using the 52-week Equator clinical trial. Two additional studies were also used to measure long-term effects.
Continue Reading
In the short-term studies, patients in the brexpiprazole group were associated with greater improvement in each subscale score from baseline to week 6 compared with the control group participants. The patients using the antipsychotic were also associated with greater improvement in 25 of 30 PANSS scale symptoms at week 6 compared with the control group participants. ....

Schizophrenia Bulletin Open , Negative Syndrome Scale , ஸ்கிசோஃப்ரினியா புல்லட்டின் திறந்த , எதிர்மறை நோய்க்குறி அளவு ,